Host-directed drug therapy for tuberculosis

September 17th, 2015 by Reto Guler

Nature Chemical Biology 11, 748 (2015). doi:10.1038/nchembio.1917

Authors: Reto Guler & Frank Brombacher

Chemical compounds designed to enhance understanding of host-pathogen interaction together with next-generation 'smart drugs' will rationally drive the discovery of promising new host-directed targets against pathogens including Mycobacterium tuberculosis, the causative agent of tuberculosis.